Tag: 3C-like protease
Pfizer’s new COVID-19 protease inhibitor drug is not just “repackaged ivermectin”
Pfizer recently announced that its new protease inhibitor-based drug was 89% effective in preventing hospitalization due to COVID-19 and it is seeking an emergency use authorization for it from the FDA. Antivaxxers claim that ivermectin targets the same protease and is being "suppressed" to protect Pfizer's profits from the new drug. What's the real story? Hint: Antivaxxers took a grain of truth...